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Introduction
• Preeclampsia is a complication 
of pregnancy that if left untreated
could result in maternal and/or fetal death.
• Preeclampsia is a pregnancy-
specific, multisystem disorder that
affects three to five percent of all
pregnancies  (Moncrieff, 2018).
• Preeclampsia is one of the leading causes
of death and severe maternal morbidity
(Mayrink, Costa, & Cecatti, 2018).
• Preeclampsia can affect the 
kidneys, liver, vasculature, and brain
(Moncrieff, 2018).
• In developed countries, 
access to antenatal care has significantly 
improved maternal and fetal outcomes, 
however, in underdeveloped countries,
preeclampsia remains a big problem.   
• Prevalence is likely
underestimated due to under-reporting in 
low-income areas (Mayrink et al., 2018)
Signs & Symptoms
• New-onset hypertension at or after
20 weeks’ gestation (BP ≥ 160/110) 
• Proteinuria
• Visual disturbances
• Severe Headache
• Epigastric Pain
• Thrombocytopenia
• Altered kidney function
• Altered liver function
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Pathophysiology
• The pathology of preeclampsia is thought to originate in the placenta, during the 
establishment of the uteroplacental circulation (Moncrieff, 2018).
• Under healthy circumstances, normal placentation occurs during the transformation of  
maternal spiral arteries from small-diameter, high-resistance arteries into low-resistance,                          
high-capacity vessels that can effectively perfuse the intervillous space  (Moncrieff, 2018).
• In preeclampsia, the spiral artery transformation is incomplete.  Cytotrophoblasts fail to 
fully penetrate spiral arteries and many are incompletely transformed  or don’t transform 
at all (Moncrieff, 2018).
• Normally, remodeling of the spiral arteries extends into the myometrium.  In preeclampsia, 
the myometrial portion of many arteries may be left unaltered.  The unaltered arteries have a 
thick, muscular wall with a functional adrenergic nerve supply, and are left as high-resistance
vessels that provide high-pressure, pulsatile flow to the placenta.  Because the blood flow to                                          
the placenta may be altered by adrenergic input, it may be under-perfused.  This results in 
placental ischemia-reperfusion injury as a result of oxidative stress (Moncrieff, 2018).
• Cytokines and anti-angiogenic proteins are released into the maternal circulation which may
alter vascular growth and permeability (Moncrieff, 2018).
• Due to the high pressure blood flow, syncytiotrophoblast particles are also released into 
maternal blood flow  (Moncrieff, 2018).
• These products of placental stress are thought to be the cause of maternal endothelial 
damage, altered homeostasis and coagulation, and increased systemic vascular resistance
(Moncrieff, 2018).
Significance
• Severe consequences of  preeclampsia include renal failure, pulmonary edema, HELLP 
syndrome (hemolysis, elevated liver enzymes, low platelets),  eclampsia, and maternal/ fetal 
death  (Moncrieff, 2018).
• About 20% of women will develop hypertension or microalbuminuria within seven years from 
a pregnancy complicated by preeclampsia (Mayrink et al., 2018)
• Women who had preeclampsia have a significantly higher risk of a myocardial infarction, 
cerebrovascular accident, or venous thromboembolism (Mayrink et al., 2018)
• Babies born prematurely (specifically before 34 weeks) may suffer from acute respiratory 
syndrome, intraventricular hemorrhage, sepsis, bronchopulmonary dysplasia, and neuro-
developmental delay  (Mayrink et al., 2018)
• Disseminated intravascular coagulation (DIC) can be a complication of preeclampsia/HELLP 
syndrome.  DIC is a life-threatening hematologic crisis resulting in microvascular thrombosis 
and uncontrolled bleeding (Erez, Mastrolia, & Thachil, 2015). 
Treatment
Nursing Implications 
Presentation of Case
• The only known cure for preeclampsia is delivery of the baby
• Obstetric guidelines recommend that low-dose aspirin therapy be 
initiated from 12 weeks gestation and continued until delivery for maximum
preventative effects for those at risk (Zhu, Huang, Zhang, Ye, & Zhang, 2018).
• According to the American College of Obstetrics and Gynecology (2018) 
low-dose aspirin should be given if at least one of the following criteria is met:
history of preeclampsia, multifetal gestation, chronic hypertension, diabetes, 
renal disease, or an autoimmune disease.  Aspirin should be considered if
more than one of the following criteria are met: nulliparity, obesity (BMI > 30), 
family history of preeclampsia, low socioeconomic status, advanced maternal 
age, or history of an adverse reaction with a previous pregnancy.
• Magnesium sulfate is a very effective medication in preventing seizure
activity in those with severe preeclampsia.  The current practice is to 
administer magnesium during labor and for 24 hours post-delivery, however,
some research may suggest that 6 hours of magnesium post delivery may be 
enough.  This would help to prevent separation of mother and baby 
(Anjum, Rajaram, & Bano, 2015). 
• Education is the most important nursing intervention that can be done to protect 
mothers and babies, before, during, and after pregnancy.
• Vigilant ongoing assessment should be performed for all pregnant women, especially,
those who are at an increased risk for developing preeclampsia. 
• Woman with a history of preeclampsia have a three to four times greater risk of developing
high blood pressure, and double the risk for heart disease and stroke 
(Preeclampsia Foundation, 2016).  
• Education should be focused on the importance of getting at least 30 minutes of cardiovascular
exercise five days per week, and strength training at least two day per week 
(Preeclampsia Foundation, 2016).
• Encourage the importance of following a heart healthy diet, rich in fruits and vegetables, high
in fiber, and low in fat (Preeclampsia Foundation, 2016).
• Nurses will provide information on maintaining a healthy body mass index
• Smoking cessation programs
• Encouraging the public to be knowledgeable about their numbers 
(blood pressure, blood glucose,  and cholesterol) 
(Muniz, 2018)
(Shutterstock, 2019)
(Wang, 2017)
Amy is a 38 year old primigravida who presented
to labor & delivery triage at 36 weeks and 3 days 
gestation with the following complaints:
headache 9/10, blurred vision, and right upper 
quadrant pain.  Amy reports good fetal movement.
Vital signs are BP 176/105, HR 105, Temp 98.3,Resp 16.
Amy stated she takes 81 mg aspirin daily as well as a
prenatal vitamin. Amy states that she has chronic 
hypertension and has diet controlled gestational 
diabetes. Amy stated to the physician “I’m supposed to 
take a medication for my blood pressure but I can’t
remember what it is and I ran out last month.” 
Amy is admitted to labor and delivery for further
monitoring.  It is decided that an induction of labor 
would be the safest option for Amy and her baby.
Neuroprotective magnesium sulfate is administered 
during labor for continued severe range blood pressures,
ongoing headache, blurred vision, and epigastric pain. 
Amy’s labor is augmented with Pitocin and after nine 
hours Amy delivers a 9 lb 2 oz baby boy. The baby is 
vigorous and crying at delivery, Apgar's are eight at one
minute of life and nine at five minutes of life.  The baby 
boy is place skin-to-skin with Amy in the delivery room. 
Thirty minutes after delivery, Amy denies any blurred 
vision or epigastric pain, but still complains of a dull
headache 5/10 and has a blood pressure of 162/100.
The doctors order Amy to remain on magnesium
sulfate for 24 hours post delivery.  Due to the frequent 
monitoring required with magnesium, Amy must remain
on the labor and delivery unit while her baby is taken to
the well-baby nursery for triage. Amy cannot keep her 
baby with her as she is alone and drowsy from the 
magnesium infusion.  Twenty-four hours have passed 
and Amy is moved to the post-partum unit and reunited
with her baby. Amy denies any symptoms and now has
a blood pressure of 132/88.  Amy was started on 30 mg
extended release Procardia and will have vital sign
checks every 4 hours while in the hospital, she will also
have a blood pressure check two weeks postpartum.  
Amy is prescribed a blood pressure cuff and will 
monitor her BP at home twice daily. 
Conclusion
• Preeclampsia can have profound effects on the 
physical, emotional, and psychosocial health of 
women and their newborns 
(Phillips & Boyd 2016). 
• Early identification and treatment of
preeclampsia is key in providing mother
and baby a safe environment for gestation and delivery.
• Identifying those at a greater risk for 
developing preeclampsia will aide in better 
treatment and better outcomes.
• Increasing community outreach programs to 
provide the underserved areas with increased access
to healthcare facilities and education regarding
preeclampsia, smoking cessation, and healthy living 
will help to protect the health of mothers and babies
in the future. 
